α-Synuclein interacts with the switch region of Rab8a in a Ser129 phosphorylation-dependent manner
暂无分享,去创建一个
Christian Griesinger | Stefan Becker | Roger S. Goody | Markus Zweckstetter | Tiago F. Outeiro | G. Braus | R. Goody | S. Becker | C. Griesinger | F. Giorgini | A. Itzen | M. Zweckstetter | C. Breda | T. Outeiro | C. Fernández | Flaviano Giorgini | Gerhard H. Braus | Carlo Breda | É. Szegõ | Guowei Yin | D. Lázaro | Aymelt Itzen | Patricia Guerreiro | Tomas Lopes da Fonseca | Sibylle E. Eisbach | Ane Martín Anduaga | Maria L. Orcellet | Éva M. Szegő | Diana F. Lázaro | Claudio O. Fernandez | Guowei Yin | Ane Martin Anduaga | Tomás Lopes da Fonseca | P. Guerreiro
[1] E. Masliah,et al. The many faces of α-synuclein: from structure and toxicity to therapeutic target , 2012, Nature Reviews Neuroscience.
[2] Nathan A. Baker,et al. Electrostatics of nanosystems: Application to microtubules and the ribosome , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[3] M. Barrachina,et al. Abnormal alpha-synuclein interactions with rab3a and rabphilin in diffuse Lewy body disease. , 2004, Neurobiology of disease.
[4] Michel Goedert,et al. Identification of two distinct synucleins from human brain , 1994, FEBS letters.
[5] J. Hardy,et al. The genetics of Parkinson's syndromes: a critical review. , 2009, Current opinion in genetics & development.
[6] S. Nakano,et al. Expression of the endocytosis regulatory proteins Rab5 and Rabaptin-5 in glial cytoplasmic inclusions from brains with multiple system atrophy. , 2000, Clinical neuropathology.
[7] Leon D. Segal,et al. Functions , 1995 .
[8] David G. Nicholls,et al. Bioenergetic analysis of isolated cerebrocortical nerve terminals on a microgram scale: spare respiratory capacity and stochastic mitochondrial failure , 2009, Journal of neurochemistry.
[9] E. Masliah,et al. Phosphorylation of Synucleins by Members of the Polo-like Kinase Family* , 2009, The Journal of Biological Chemistry.
[10] Leonidas Stefanis,et al. α-Synuclein Overexpression in PC12 and Chromaffin Cells Impairs Catecholamine Release by Interfering with a Late Step in Exocytosis , 2006, The Journal of Neuroscience.
[11] A. Davies,et al. Induction of neuronal death by α‐synuclein , 2000, The European journal of neuroscience.
[12] E. Martínez-Alonso,et al. Golgi fragmentation is Rab and SNARE dependent in cellular models of Parkinson’s disease , 2012, Histochemistry and Cell Biology.
[13] R. Barbour,et al. Phosphorylation of Ser-129 Is the Dominant Pathological Modification of α-Synuclein in Familial and Sporadic Lewy Body Disease* , 2006, Journal of Biological Chemistry.
[14] Robert L. Nussbaum,et al. Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .
[15] A. Fink,et al. Role of Different Regions of α-Synuclein in the Assembly of Fibrils† , 2007 .
[16] T. Outeiro,et al. Alpha-synuclein: from secretion to dysfunction and death , 2012, Cell Death and Disease.
[17] C. Dobson,et al. Structure and properties of a complex of α-synuclein and a single-domain camelid antibody. , 2010, Journal of molecular biology.
[18] C. Griesinger,et al. Release of long-range tertiary interactions potentiates aggregation of natively unstructured alpha-synuclein. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[19] E. Masliah,et al. α-Synuclein is phosphorylated in synucleinopathy lesions , 2002, Nature Cell Biology.
[20] E. Waxman,et al. Characterization of kinases involved in the phosphorylation of aggregated α‐synuclein , 2011, Journal of neuroscience research.
[21] J. Troncoso,et al. Accumulation of Toxic α-Synuclein Oligomer within Endoplasmic Reticulum Occurs in α-Synucleinopathy In Vivo , 2012, The Journal of Neuroscience.
[22] S. Lindquist,et al. The Parkinson's disease protein alpha-synuclein disrupts cellular Rab homeostasis. , 2008, Proceedings of the National Academy of Sciences of the United States of America.
[23] J. Kenney,et al. Microtubule-associated Protein 1B Is a Component of Cortical Lewy Bodies and Binds α-Synuclein Filaments* , 2000, The Journal of Biological Chemistry.
[24] S. Lindquist,et al. The Parkinson's disease protein α-synuclein disrupts cellular Rab homeostasis , 2008, Proceedings of the National Academy of Sciences.
[25] R. Beyer,et al. Rab11a and HSP90 Regulate Recycling of Extracellular α-Synuclein , 2009, The Journal of Neuroscience.
[26] V. Subramaniam,et al. Dependence of α-synuclein aggregate morphology on solution conditions , 2002 .
[27] V. Subramaniam,et al. NMR of α‐synuclein–polyamine complexes elucidates the mechanism and kinetics of induced aggregation , 2004, The EMBO journal.
[28] Ad Bax,et al. Multiple tight phospholipid-binding modes of alpha-synuclein revealed by solution NMR spectroscopy. , 2009, Journal of molecular biology.
[29] W. Bender,et al. A Drosophila model of Parkinson's disease , 2000, Nature.
[30] J. Trojanowski,et al. Alpha-synuclein-induced aggregation of cytoplasmic vesicles in Saccharomyces cerevisiae. , 2007, Molecular biology of the cell.
[31] Virgil L. Woods,et al. Structure and properties of α-synuclein and other amyloids determined at the amino acid level , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[32] M G Spillantini,et al. Alpha-synuclein in Lewy bodies. , 1997, Nature.
[33] H. Stenmark. Rab GTPases as coordinators of vesicle traffic , 2009, Nature Reviews Molecular Cell Biology.
[34] R. Zhai,et al. Assaying Locomotor, Learning, and Memory Deficits in Drosophila Models of Neurodegeneration , 2011, Journal of visualized experiments : JoVE.
[35] R. Goody,et al. Chaperone-assisted production of active human Rab8A GTPase in Escherichia coli. , 2009, Protein expression and purification.
[36] P. Novick,et al. An internal domain of Exo70p is required for actin-independent localization and mediates assembly of specific exocyst components. , 2009, Molecular biology of the cell.
[37] J. Trojanowski,et al. Synucleins Are Developmentally Expressed, and α-Synuclein Regulates the Size of the Presynaptic Vesicular Pool in Primary Hippocampal Neurons , 2000, The Journal of Neuroscience.
[38] S. Koyama,et al. Authentically Phosphorylated α-Synuclein at Ser129 Accelerates Neurodegeneration in a Rat Model of Familial Parkinson's Disease , 2011, The Journal of Neuroscience.
[39] P. Aebischer,et al. Polo-like kinase 2 regulates selective autophagic α-synuclein clearance and suppresses its toxicity in vivo , 2013, Proceedings of the National Academy of Sciences.
[40] Thomas C. Südhof,et al. α-Synuclein Cooperates with CSPα in Preventing Neurodegeneration , 2005, Cell.
[41] S. Tenreiro,et al. PLK2 Modulates α-Synuclein Aggregation in Yeast and Mammalian Cells , 2013, Molecular Neurobiology.
[42] T. Iwatsubo,et al. A systematic RNAi screen reveals involvement of endocytic pathway in neuronal dysfunction in alpha-synuclein transgenic C. elegans. , 2008, Human molecular genetics.
[43] K. Chung,et al. Induction of Neuronal Cell Death by Rab5A-dependent Endocytosis of α-Synuclein* , 2001, The Journal of Biological Chemistry.
[44] M. Feany,et al. Alpha-synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease. , 2005, Nature neuroscience.
[45] M. Feany,et al. α-Synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease , 2005, Nature Neuroscience.
[46] T. Iwatsubo,et al. Phosphorylation of α-Synuclein Protein at Ser-129 Reduces Neuronal Dysfunction by Lowering Its Membrane Binding Property in Caenorhabditis elegans* , 2012, The Journal of Biological Chemistry.
[47] D. Lambright,et al. Structural Mechanisms for Regulation of Membrane Traffic by Rab GTPases , 2009, Traffic.
[48] Philippe Amouyel,et al. α-synuclein locus duplication as a cause of familial Parkinson's disease , 2004, The Lancet.
[49] D. Neill,et al. Aggregates from mutant and wild‐type α‐synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of β‐sheet and amyloid‐like filaments , 1998, FEBS letters.
[50] H. Braak,et al. Staging of brain pathology related to sporadic Parkinson’s disease , 2003, Neurobiology of Aging.
[51] C. Dobson,et al. Mapping long-range interactions in alpha-synuclein using spin-label NMR and ensemble molecular dynamics simulations. , 2005, Journal of the American Chemical Society.
[52] Nikolaus R. McFarland,et al. &agr;-Synuclein S129 Phosphorylation Mutants Do Not Alter Nigrostriatal Toxicity in a Rat Model of Parkinson Disease , 2009, Journal of neuropathology and experimental neurology.
[53] S. Lindquist,et al. α-Synuclein Blocks ER-Golgi Traffic and Rab1 Rescues Neuron Loss in Parkinson's Models , 2006, Science.
[54] R. Goody,et al. GTPases involved in vesicular trafficking: structures and mechanisms. , 2011, Seminars in cell & developmental biology.
[55] Fred H. Gage,et al. In vivo demonstration that α-synuclein oligomers are toxic , 2011, Proceedings of the National Academy of Sciences.
[56] Michele Vendruscolo,et al. Amyloid-like Aggregates Sequester Numerous Metastable Proteins with Essential Cellular Functions , 2011, Cell.
[57] M. Zweckstetter,et al. Mars - robust automatic backbone assignment of proteins , 2004, Journal of biomolecular NMR.
[58] Akihiko Iwai,et al. The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system , 1995, Neuron.
[59] R. Hawkins,et al. α‐Synuclein produces a long‐lasting increase in neurotransmitter release , 2004, The EMBO journal.
[60] B. Hyman,et al. Interaction of alpha-synuclein and synphilin-1: effect of Parkinson's disease-associated mutations. , 2001, Journal of neurochemistry.
[61] C. Dobson,et al. Conserved C-terminal charge exerts a profound influence on the aggregation rate of α-synuclein. , 2011, Journal of molecular biology.
[62] E. Masliah,et al. alpha-Synuclein is phosphorylated in synucleinopathy lesions. , 2002, Nature cell biology.
[63] Chul-hak Yang,et al. Structural and functional implications of C-terminal regions of alpha-synuclein. , 2002, Biochemistry.
[64] Virgil L. Woods,et al. Structure and properties of alpha-synuclein and other amyloids determined at the amino acid level. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[65] K. Brunden,et al. Lewy Body-like α-Synuclein Aggregates Resist Degradation and Impair Macroautophagy*♦ , 2013, The Journal of Biological Chemistry.
[66] E. Masliah,et al. Suppression of α-synuclein toxicity and vesicle trafficking defects by phosphorylation at S129 in yeast depends on genetic context. , 2012, Human molecular genetics.
[67] H. Jäckle,et al. Pre‐fibrillar α‐synuclein variants with impaired β‐structure increase neurotoxicity in Parkinson's disease models , 2009, The EMBO journal.
[68] Bradley T. Hyman,et al. Formation of Toxic Oligomeric α-Synuclein Species in Living Cells , 2008, PloS one.
[69] T. Südhof,et al. Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration. , 2005, Cell.
[70] M. L. Schmidt,et al. α-Synuclein in Lewy bodies , 1997, Nature.
[71] D. Eliezer,et al. Conformational properties of alpha-synuclein in its free and lipid-associated states. , 2001, Journal of molecular biology.
[72] Sara M. Butterfield,et al. Amyloidogenic Protein—Membrane Interactions: Mechanistic Insight from Model Systems , 2010 .
[73] M. Chesselet,et al. In vivo alpha-synuclein overexpression in rodents: A useful model of Parkinson's disease? , 2008, Experimental Neurology.
[74] Jorgensen,et al. On the conformational properties of , 2000, The Journal of organic chemistry.
[75] J. Baum,et al. Detection of transient interchain interactions in the intrinsically disordered protein alpha-synuclein by NMR paramagnetic relaxation enhancement. , 2010, Journal of the American Chemical Society.
[76] M. Cookson. α-Synuclein and neuronal cell death , 2009, Molecular Neurodegeneration.
[77] Normand L. Frigon,et al. Polo-like Kinase 2 (PLK2) Phosphorylates α-Synuclein at Serine 129 in Central Nervous System*S⃞ , 2009, Journal of Biological Chemistry.
[78] Ad Bax,et al. Structure and Dynamics of Micelle-bound Human α-Synuclein* , 2005, Journal of Biological Chemistry.
[79] Heidi Phillips,et al. Mice Lacking α-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine System , 2000, Neuron.
[80] M. Barrachina,et al. Abnormal α-synuclein interactions with rab3a and rabphilin in diffuse Lewy body disease , 2004, Neurobiology of Disease.
[81] S E Ide,et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. , 1997, Science.
[82] D. Selkoe,et al. α‐Synuclein and Polyunsaturated Fatty Acids Promote Clathrin‐Mediated Endocytosis and Synaptic Vesicle Recycling , 2009, Traffic.
[83] I. Forsythe,et al. Rab11 rescues synaptic dysfunction and behavioural deficits in a Drosophila model of Huntington's disease , 2012, Human molecular genetics.
[84] D. Sheff,et al. Rab8 regulates basolateral secretory, but not recycling, traffic at the recycling endosome. , 2008, Molecular Biology of the Cell.
[85] O. Isacson,et al. Functional enhancement and protection of dopaminergic terminals by RAB3B overexpression , 2009, Proceedings of the National Academy of Sciences.
[86] B. Hyman,et al. α-Synuclein–enhanced green fluorescent protein fusion proteins form proteasome sensitive inclusions in primary neurons , 2001, Neuroscience.
[87] Philippe Amouyel,et al. Alpha-synuclein locus duplication as a cause of familial Parkinson's disease. , 2004, Lancet.
[88] P. Fraser,et al. α-Synuclein Membrane Association Is Regulated by the Rab3a Recycling Machinery and Presynaptic Activity*♦ , 2013, The Journal of Biological Chemistry.
[89] Chul-hak Yang,et al. Structural and Functional Implications of C-Terminal Regions of α-Synuclein† , 2002 .
[90] R. Goody,et al. A structural basis for Lowe syndrome caused by mutations in the Rab‐binding domain of OCRL1 , 2011, The EMBO journal.
[91] Ora Schueler-Furman,et al. Rosetta FlexPepDock web server—high resolution modeling of peptide–protein interactions , 2011, Nucleic Acids Res..
[92] E. Dalfo,et al. α-Synuclein binding to rab3a in multiple system atrophy , 2005, Neuroscience Letters.
[93] H. Jäckle,et al. Pre-Fibrillar α-Synuclein Mutants Cause Parkinson's Disease-Like Non-Motor Symptoms in Drosophila , 2011, PloS one.
[94] H. Lashuel,et al. Provided for Non-commercial Research and Educational Use Only. Not for Reproduction, Distribution or Commercial Use. Author's Personal Copy Role of Post-translational Modifications in Modulating the Structure, Function and Toxicity of A-synuclein: Implications for Parkinson's Disease Pathogenesis an , 2022 .
[95] A. Fink,et al. Role of different regions of alpha-synuclein in the assembly of fibrils. , 2007, Biochemistry.
[96] S. Lindquist,et al. α-Synuclein: membrane interactions and toxicity in Parkinson's disease. , 2010, Annual review of cell and developmental biology.
[97] Henning Stahlberg,et al. The fold of α-synuclein fibrils , 2008, Proceedings of the National Academy of Sciences.
[98] P. Højrup,et al. α-Synuclein Binds to Tau and Stimulates the Protein Kinase A-catalyzed Tau Phosphorylation of Serine Residues 262 and 356* , 1999, The Journal of Biological Chemistry.
[99] R. Nussbaum,et al. Proteomics Analysis Identifies Phosphorylation-dependent α-Synuclein Protein Interactions *S , 2008, Molecular & Cellular Proteomics.
[100] Nir London,et al. Sub‐angstrom modeling of complexes between flexible peptides and globular proteins , 2010, Proteins.
[101] C. Burd,et al. Aggregation of α-Synuclein in S. cerevisiae is Associated with Defects in Endosomal Trafficking and Phospholipid Biosynthesis , 2011, Journal of Molecular Neuroscience.
[102] V. Subramaniam,et al. Dependence of alpha-synuclein aggregate morphology on solution conditions. , 2002, Journal of molecular biology.
[103] D. Sulzer,et al. Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. , 2000, Neuron.
[104] D. Craik,et al. Studies of protein-ligand interactions by NMR. , 1997, Methods in molecular biology.
[105] Richard Paylor,et al. Synaptic Vesicle Depletion Correlates with Attenuated Synaptic Responses to Prolonged Repetitive Stimulation in Mice Lacking α-Synuclein , 2002, The Journal of Neuroscience.
[106] M. Feany,et al. Parkinson's disease: Insights from non-traditional model organisms , 2010, Progress in Neurobiology.
[107] P. Lansbury,et al. Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. , 2003, Annual review of neuroscience.
[108] I. Forsythe,et al. Rab 11 rescues synaptic dysfunction and behavioural deficits in a Drosophila model of Huntington ’ s disease , 2012 .
[109] E. Waxman,et al. Molecular mechanisms of alpha-synuclein neurodegeneration. , 2009, Biochimica et biophysica acta.
[110] W. Gibb. Neuropathology of Parkinson's disease and related syndromes. , 1992, Neurologic clinics.
[111] V. Subramaniam,et al. Impact of the acidic C-terminal region comprising amino acids 109-140 on alpha-synuclein aggregation in vitro. , 2004, Biochemistry.
[112] T. Südhof,et al. α-Synuclein Promotes SNARE-Complex Assembly in Vivo and in Vitro , 2010, Science.
[113] V. Uversky,et al. Polycation-induced oligomerization and accelerated fibrillation of human alpha-synuclein in vitro. , 2003, Protein science : a publication of the Protein Society.
[114] T. Gómez-Isla,et al. Abnormal alpha-synuclein interactions with Rab proteins in alpha-synuclein A30P transgenic mice. , 2004, Journal of neuropathology and experimental neurology.
[115] Jennifer C. Lee,et al. α-Synuclein Interacts with Glucocerebrosidase Providing a Molecular Link between Parkinson and Gaucher Diseases* , 2011, The Journal of Biological Chemistry.
[116] S. Arawaka,et al. The role of Ser129 phosphorylation of α-synuclein in neurodegeneration of Parkinson’s disease: a review of in vivo models , 2013, Reviews in the neurosciences.
[117] B. Hyman,et al. Interaction of α‐synuclein and synphilin‐1: effect of Parkinson's disease‐associated mutations , 2001 .
[118] V. Uversky,et al. Polycation‐induced oligomerization and accelerated fibrillation of human α‐synuclein in vitro , 2003 .
[119] Markus Zweckstetter,et al. Backbone assignment of proteins with known structure using residual dipolar couplings , 2004, Journal of biomolecular NMR.
[120] The relation of hostile nonverbal communication styles to popularity in preadolescent children. , 1989, The Journal of genetic psychology.